Balyasny Asset Management
SCLN

Balyasny Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Balyasny Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
2017
Q3 		$345K Buy
2017
Q2 		– Sell
2017
Q1 		$172K Sell
2016
Q4 		$202K Buy
2016
Q3 		$165K Buy
2016
Q2 		$146K Sell
2016
Q1 		$180K Buy